GlaxoSmithKline PLC — Investor Relations & Filings
Filings indexed
7,016
across all filing types
Latest filing
2026-01-05
Regulatory Filings
Country
GB
United Kingdom
Listing
IL
GSK
GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K Filing | 2026-01-05 | English | |
| GSK TO LOWER DRUG PRICES AND EXPAND ACCESS IN US | 2025-12-23 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2025-12-22 | English | |
| Director/PDMR Shareholding | 2025-12-22 | English | |
| TRANSACTION IN OWN SHARES | 2025-12-22 | English | |
| GSK to lower drug prices and expand access in US | 2025-12-22 | English |
Browse filings by year
27 years- 2026 241 filings
- 2025 710 filings
- 2024 333 filings
- 2023 305 filings
- 2022 417 filings
- 2021 351 filings
- 2020 338 filings
- 2019 338 filings
- 2018 353 filings
- 2017 356 filings
- 2016 528 filings
- 2015 398 filings
- 2014 570 filings
- 2013 728 filings
- 2012 473 filings
- 2011 402 filings
- 2010 158 filings
- 2009 2 filings
- 2008 2 filings
- 2007 2 filings
- 2006 2 filings
- 2005 1 filing
- 2004 1 filing
- 2003 1 filing
- 2002 2 filings
- 2001 3 filings
- 2000 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 28076992 | 6-K Filing | 2026-01-05 | English | ||
|
2025
14 filings
| |||||
| 11414402 | GSK TO LOWER DRUG PRICES AND EXPAND ACCESS IN US | 2025-12-23 | English | ||
| 11414403 | DIRECTOR/PDMR SHAREHOLDING | 2025-12-22 | English | ||
| 10624051 | Director/PDMR Shareholding | 2025-12-22 | English | ||
| 11414405 | TRANSACTION IN OWN SHARES | 2025-12-22 | English | ||
| 10568052 | GSK to lower drug prices and expand access in US | 2025-12-22 | English | ||
| 10565136 | Transaction in Own Shares | 2025-12-22 | English | ||
| 11414404 | TRANSACTION IN OWN SHARES | 2025-12-19 | English | ||
| 10377743 | Transaction in Own Shares | 2025-12-19 | English | ||
| 11414406 | TRANSACTION IN OWN SHARES | 2025-12-18 | English | ||
| 10361263 | Transaction in Own Shares | 2025-12-18 | English | ||
| 11414407 | EXDENSUR (DEPEMOKIMAB ULLA) APPROVED BY US FDA | 2025-12-17 | English | ||
| 11414408 | TRANSACTION IN OWN SHARES | 2025-12-17 | English | ||
| 10220202 | Exdensur (depemokimab ulla) approved by US FDA | 2025-12-17 | English | ||
| 10220089 | Transaction in Own Shares | 2025-12-17 | English | ||
Financials
Loading financials…
We couldn't load the financials
No data available yet
We have extracted financials for GlaxoSmithKline PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GlaxoSmithKline PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5262/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5262 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5262 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5262 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5262}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GlaxoSmithKline PLC (id: 5262)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.